Articles From: Apollo Senior Floating Rate Fund Inc. Declares July 2014 Monthly Distribution of $0.0957 Per Share to BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment


(NYSE:AFT) - Apollo Senior Floating Rate Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of July, 2014 of $0.0957 per common share, payable on the date noted below.
Sign-up for Apollo Senior Floating Rate Fund Inc. Declares July 2014 Monthly Distribution of $0.0957 Per Share investment picks
(NYSE: AIF) - Apollo Tactical Income Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of July, 2014 of $0.117 per common share, payable on the date noted below.
Sign-up for Apollo Tactical Income Fund Inc. Declares July 2014 Monthly Distribution of $0.117 Per Share investment picks
SUGAR LAND, Texas, June 16, 2014 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (Nasdaq:AAOI) , a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, will attend the Fiber to the Home (FTTH) Conference taking place on June 23-25 in Fort Lauderdale, Florida.
Sign-up for Applied Optoelectronics Highlights WDM-PON Products at FTTH Conference investment picks
SAN DIEGO, June 16, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) , a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced the launch of Vitaros ® , Apricus' novel topical on-demand treatment for erectile dysfunction ("ED"). Vitaros will be marketed in the United Kingdom by Takeda Pharmaceuticals International GmbH.
Sign-up for Apricus Biosciences Announces the Launch of Its Topical Treatment for Erectile Dysfunction Vitaros(R) in the United Kingdom investment picks
2014/6/16
WASHINGTON , June 16, 2014 /PRNewswire-USNewswire/ -- Today, the National Park Foundation , the official charity of America's national parks, announced a $400,000 contribution from Aramark to the Foundation's Centennial Campaign, marking the first corporate sponsorship from a national park concessionaire in support of the National Park Service's 100th anniversary in 2016.
Sign-up for Aramark Contributes $400,000 to National Park Foundation in Honor of National Park Service's Centennial Anniversary investment picks
2014/6/16
Argent Energy Trust confirms June 2014 distribution Canada NewsWire /NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/ CALGARY , June 16, 2014 /CNW/ - Argent Energy Trust ("Argent" or the "Trust") ( TSX: AET.UN ) today announced that the cash distribution to be paid on July 23, 2014 , in respect of the period from and including June 1 to June 30, 2014 , for unitholders of record on June 30, 2014 will be $0.02 per trust unit.
Sign-up for Argent Energy Trust confirms June 2014 distribution investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, is set to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes .
Sign-up for Arrowhead Research Set to Join Russell 3000 Index investment picks
ITASCA, Ill , June 16, 2014 /PRNewswire/ -- Arthur J.
Sign-up for Arthur J. Gallagher & Co. Completes Acquisition Of Wesfarmers' Insurance Brokerage Operations investment picks
Following the decisive victory by its premier distilled spirit in a recent European vodka competition, the Aristocrat Group Corp.
Sign-up for ASCC: Russian Vodka Ban Could Open Up New Opportunities in Europe investment picks
2014/6/16
By Daniel Inman Japanese stocks moved lower on Monday as concerns over Iraq resulted in a stronger yen, while mining shares weighed on the Australian market.
Sign-up for Asia stocks lower; yen gains on Iraq conflict investment picks
2014/6/16
Customers Get Access to Award-Winning TV and High Speed Internet Services MONTGOMERY, Ala.
Sign-up for AT&T U-verse Arrives in Montgomery, AL investment picks
2014/6/16
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0952182001&sourceType=1 http://www.ccnmatthews.com/logos/20060404-main_atco-group.jpg CALGARY, ALBERTA --
Sign-up for ATCO Electric Yukon: New Name, New Energy investment picks
SAN DIEGO and BERKELEY, Calif., June 16, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Annie's, Inc. (NYSE: BNNY) has filed a federal securities fraud class action complaint in the U.S. District Court for the Northern District of California.
Sign-up for Attention Annie's, Inc. Investors: Annie's Misled Investors According to a Recently Filed Class Action investment picks
AutoCanada Inc. Announcement Regarding Dealer Group Acquisition Canada NewsWire EDMONTON , June 16, 2014 /CNW/ - AutoCanada Inc. ("AutoCanada" or the "Company") (TSX: ACQ) announced today that further to its prior announcement on April 29, 2014 regarding the proposed acquisition of a dealer group, AutoCanada confirms that it has signed agreements to purchase from the Hyatt Automotive Group Inc. or its affiliates, six dealerships comprised of Infiniti, Nissan, Volkswagen, Mitsubishi and two Hyundai dealerships, all of which are located in Calgary, Alberta .
Sign-up for AutoCanada Inc. Announcement Regarding Dealer Group Acquisition investment picks
Avigilon Broadens Access Control Portfolio Canada NewsWire Latest addition offers optimized solutions for projects of all sizes VANCOUVER , June 16, 2014 /CNW/ - Avigilon Corporation ("Avigilon") (TSX:AVO) , a leading global provider of end-to-end security solutions, today introduced the latest version of its Access Control Manager (ACM) platform to its innovative product portfolio.
Sign-up for Avigilon Broadens Access Control Portfolio investment picks
2014/6/16
Manufacturers today continue to struggle with the complexity of balancing supply and demand in their aftermarket supply chains as manufacturing and consumption are more often regionally disaggregated.
Sign-up for Avnet Electronics Marketing Executive to Keynote at Interlog 2014 Conference investment picks
ALACHUA, Fla., June 16, 2014 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (Nasdaq:AXGN) , a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, announced today that it was included on a preliminary list of additions to the Russell Microcap® Index according to information posted by Russell Investments on June 13, 2014.
Sign-up for AxoGen, Inc. on Preliminary List of Additions to Russell Microcap(R) Index investment picks
2014/6/16
http://media.marketwire.com/attachments/201309/184762_AXXELogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1123842&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Axxess Pharma Expands Global Sales With Initial Purchase Order From Australian Distributor Hardcore Beverages investment picks
CRYSTAL RIVER, Fla.
Sign-up for B-Scada Posts Record Quarter investment picks
2014/6/16
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G017046-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/6/16/11G017046/Scotiabank-logo-780364326799.jpg TORONTO, ON--(Marketwired - June 16, 2014) - While 39% of Canada's baby boomer generation agree retirement planning should begin when people enter the workplace, only 9% actually thought about their retirement when they entered the workforce.
Sign-up for Baby Boomer Remorse Mounts Over Retirement Planning: Scotiabank Retirement Study investment picks
Barnes Group Inc. (NYSE: B), an international industrial and aerospace manufacturer and service provider, today announced that it entered into an aerospace aftermarket Component Repair Program (CRP) agreement with General Electric Company (NYSE: GE). The agreement provides the Company, as one of a few GE licensed suppliers, the right to sell certain aftermarket component repair services for the CFM56* engines over the life of the program directly to the market.
Sign-up for Barnes Group Inc. Announces New Aerospace Aftermarket Component Repair Program investment picks
2014/6/16
Baskin-Robbins Introduces New Summer Flavors and Sand Pail Cake as the Perfect Ways to Celebrate the Season with Friends and Family CANTON, Mass.
Sign-up for Baskin-Robbins Offers Guests A Lineup Of Frozen Treats To Beat The Heat This Summer Season investment picks
RALEIGH, N.C., June 16, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that the Company's CEO, Ken Reali, will present at the JMP Securities Healthcare Conference in New York on June 24, 2014.
Sign-up for Baxano Surgical to Present at JMP Securities Healthcare Conference investment picks
2014/6/16
Vault 51 secure offline storage generates over $80,000 in initial gross sales DALLAS , June 16, 2014 /PRNewswire/ -- Bayside Corp.
Sign-up for Bayside Corp. Announces Gross Sales Figures of Vault 51 investment picks
RingCentral, Inc .
Sign-up for Belly Utilizes the Perks of a Cloud-Based Phone System with RingCentral investment picks
Today Biogen Idec (NASDAQ:BIIB) and AbbVie (NYSE:ABBV) announced positive top-line results from the Phase 3 DECIDE clinical trial, designed to evaluate the superiority of once-monthly, subcutaneous daclizumab high-yield process (DAC HYP) when compared to intramuscular interferon beta-1a (IFN β-1a), as a potential treatment for relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS). Results showed that DAC HYP was superior on the study’s primary endpoint, demonstrating a statistically significant 45 percent reduction in annualized relapse rate (ARR) compared to IFN β-1a (p<0.0001). “The results of the DECIDE study are compelling, with DAC HYP demonstrating robust efficacy compared to a current standard of MS care,” said Gilmore O’Neill, vice president, Global Neurology Clinical Development, Biogen Idec.
Sign-up for Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis investment picks
2014/6/16
BioLineRx Ltd.
Sign-up for BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Apollo Senior Floating Rate Fund Inc. Declares July 2014 Monthly Distribution of $0.0957 Per Share to BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices